Journal
APPLIED RADIATION AND ISOTOPES
Volume 154, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.apradiso.2019.108893
Keywords
Targeted alpha therapy (TAT); Compton SPECT imaging; Ac-225 radionuclide
Categories
Funding
- Korea Institute of Radiological and Medical Science (KIRAMS) - Ministry of Science and ICT(MSIT), Republic of Korea [50462-2019]
Ask authors/readers for more resources
In this study, the performance of a Compton Single Photon Emission Computed Tomography (SPECT) imager when in vivo monitoring the position and distribution of (225)AC radionuclide in targeted alpha therapy (TAT) was evaluated. When (225)AC radionuclide, which emits various gamma-rays (218 and 440 keV), is used in TAT, both the photoelectric and Compton scattering events can be used for image reconstruction. Moreover, all information pertaining to the various gamma-rays of the (225)AC radionuclide can be individually or simultaneously utilized in the reconstructed image. Three types of simulation phantoms and a quantitative evaluation method were used to compare the performance of the Compton SPECT imager to that of conventional SPECT imaging, which uses only photoelectric events, and the results demonstrated that the Compton SPECT imager exhibited a higher performance as the effective count for the image reconstruction was higher. To verify the accuracy of the position and distribution of the Ac-225 radionuclide that had been inserted into the phantom, reconstructed images of the various gamma-rays were combined with cross-sectional images of the human phantom and all combined images were found to match the predetermined simulation conditions. In conclusion, the simulation results demonstrated the feasibility of the in vivo monitoring of the position and distribution of Ac-225 radionuclide using the gamma-rays in TAT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available